Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury

Trial Profile

Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Lafutidine (Primary) ; Aspirin; Loxoprofen
  • Indications NSAID-induced gastric damage
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top